GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
- First Posted Date
- 2006-12-15
- Last Posted Date
- 2017-08-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 180
- Registration Number
- NCT00412191
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
- Conditions
- Hepatitis B
- Interventions
- Biological: Engerix™-B Kinder
- First Posted Date
- 2006-12-14
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 301
- Registration Number
- NCT00411697
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Shortness Of Breath Questionnaire Validation Study
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-12-14
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT00411372
Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart
- Conditions
- Atherosclerosis
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 72
- Registration Number
- NCT00411073
- Locations
- 🇺🇸
GSK Investigational Site, Evansville, Indiana, United States
Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin
- Conditions
- Osteoarthritis
- Interventions
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2017-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 32
- Registration Number
- NCT00411190
- Locations
- 🇧🇪
GSK Investigational Site, Liège, Belgium
Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
- Conditions
- Leukaemia, Lymphocytic, Chronic
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 61
- Registration Number
- NCT00410163
- Locations
- 🇬🇧
GSK Investigational Site, Plymouth, Devon, United Kingdom
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 96
- Registration Number
- NCT00410371
- Locations
- 🇺🇸
GSK Investigational Site, Lincoln, Nebraska, United States
A Study Of BOTOX For The Treatment Of Glabellar Lines
- Conditions
- Glabellar Lines
- Interventions
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 256
- Registration Number
- NCT00408785
- Locations
- 🇨🇳
GSK Investigational Site, Shanghai, China
Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 6
- Registration Number
- NCT00406003
- Locations
- 🇨🇳
GSK Investigational Site, Beijing, China
Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
- Conditions
- TetanusDiphtheriaAcellular Pertussis
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT00406562
- Locations
- 🇨🇳
GSK Investigational Site, Suining, China